Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions
- 1 January 2003
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 138 (1) , 177-187
- https://doi.org/10.1038/sj.bjp.0705010
Abstract
1 The present study was performed to evaluate the presence and the physiological consequences of butyrylcholinesterase (BChE) inhibition on isolated phrenic-hemidiaphragm preparations from normal mice expressing acetylcholinesterase (AChE) and BChE, and from AChE-knockout mice (AChE(-/-)) expressing only BChE. 2 Histochemical and enzymatic assays revealed abundance of AChE and BChE in normal mature neuromuscular junctions (NMJs). 3 In normal NMJs, in which release was reduced by low Ca(2+)/high Mg(2+) medium BChE inhibition with tetraisopropylpyrophosphoramide (iso-OMPA) or bambuterol decreased ( approximately 50%) evoked quantal release, while inhibition of AChE with fasciculin-1, galanthamine (10, 20 micro M) or neostigmine (0.1-1 micro M) increased (50-80%) evoked quantal release. Inhibition of both AChE and BChE with galanthamine (80 micro M), neostigmine (3-10 micro M), O-ethylS-2-(diisopropylamino)ethyl-methylphosphono-thioate (MTP) or phospholine decreased evoked transmitter release (20-50%). 4 In AChE(-/-) NMJs, iso-OMPA pre-treatment decreased evoked release. 5 Muscarinic toxin-3 decreased evoked release in both AChE(-/-) and normal NMJs treated with low concentrations of neostigmine, galanthamine or fasciculin-1, but had no effect in normal NMJs pretreated with iso-OMPA, bambuterol, MTP and phospholine. 6 In normal and AChE(-/-) NMJs pretreatment with iso-OMPA failed to affect the time course of miniature endplate potentials and full-sized endplate potentials. 7 Overall, our results suggest that inhibition or absence of AChE increases evoked quantal release by involving muscarinic receptors (mAChRs), while BChE inhibition decreases release through direct or indirect mechanisms not involving mAChRs. BChE apparently is not implicated in limiting the duration of acetylcholine action on postsynaptic receptors, but is involved in a presynaptic modulatory step of the release process.Keywords
This publication has 43 references indexed in Scilit:
- Genetic Analysis of Collagen Q: Roles in Acetylcholinesterase and Butyrylcholinesterase Assembly and in Synaptic Structure and FunctionThe Journal of cell biology, 1999
- Cholinesterase activity in human pulmonary arteries and veinsBritish Journal of Pharmacology, 1997
- A toxin from the green mamba Dendroaspis angusticeps: Amino acid sequence and selectivity for muscarinic m4 receptorsFEBS Letters, 1994
- Analysis of the organophosphate‐induced electromyographic response to repetitive nerve stimulation: Paradoxical response to edrophonium and D‐TubocurarineMuscle & Nerve, 1991
- Presynaptic Receptors in the Neuromuscular JunctionAnnals of the New York Academy of Sciences, 1990
- Role of butyrylcholinesterase in canine tracheal smooth muscle functionFEBS Letters, 1990
- Reciprocal regulation of acetylcholinesterase and butyrylcholinesterase in mammalian skeletal muscleDevelopmental Biology, 1987
- 4-Aminoquinoline-induced ‘giant’ miniature endplate potentials at mammalian neuromuscular junctionsProceedings of the Royal Society of London. B. Biological Sciences, 1982
- Parallel regulation of acetylcholinesterase and pseudocholinesterase in normal, denervated and dystrophic chicken skeletal muscleNature, 1979
- ACETYL DISULFIDE, (CH3COS)2, A MAJOR ACTIVE COMPONENT IN THE THIOLACETIC ACID HISTOCHEMICAL METHOD FOR ACETYLCHOLINESTERASEJournal of Histochemistry & Cytochemistry, 1968